KYMR
Kymera Therapeutics Inc
Price:  
28.80 
USD
Volume:  
665,150.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KYMR WACC - Weighted Average Cost of Capital

The WACC of Kymera Therapeutics Inc (KYMR) is 7.4%.

The Cost of Equity of Kymera Therapeutics Inc (KYMR) is 7.45%.
The Cost of Debt of Kymera Therapeutics Inc (KYMR) is 7.75%.

Range Selected
Cost of equity 6.50% - 8.40% 7.45%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 8.50% 7.75%
WACC 6.5% - 8.4% 7.4%
WACC

KYMR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.58 0.62
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 7.00% 8.50%
After-tax WACC 6.5% 8.4%
Selected WACC 7.4%